Author: GlobeNewswire

CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…

LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and…

SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that its chief medical officer,…

NEW YORK, Oct. 12, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing…

Study Approval Paves the Way for Trial Participants to Begin Taking ApabetaloneCALGARY, Alberta, Oct. 12, 2021 (GLOBE NEWSWIRE) — Resverlogix…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September…

MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing,…

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…

MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering…

COPENHAGEN, Denmark, Oct. 12, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology…